Based on the critical roles of SIRT1 and NF-κB in regulating lipid metabolism and inflammation and the potential capacity of HQT to prevent and control NAFLD, we hypothesized that HQT ameliorates NAFLD through the SIRT1 and NF-κB signaling pathways. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.